PER capita Australians spend more out of pocket on their health than citizens of all G7 countries other than the United States. It is therefore no surprise many Australians forgo or delay taking the medicines they need. According to the Australian Bureau of Statistics’ most recent Patient Experience in Australia Survey (2020–2021), 4.4% of Australians …
Importing medicines from overseas: guidance needed Read More »
In the mid 2010s, breakthrough medicines that promised to cure hepatitis C came onto the market. The catch was, the pharmaceutical company Gilead set the price of up to £70 000 for a 3-month course of treatment. No government would pay that much given the number of people with hepatitis C. In the UK alone, it …
Efforts have been ongoing in the ICANN community to develop a better understanding of its role in the combat of abuse. This theme has been rising in prominence every year since 2018, and 2021 appears to be the tipping point, in which consensus has built around the idea that more can be accomplished in terms …